SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-20-013055
Filing Date
2020-06-12
Accepted
2020-06-12 17:12:22
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM S-3 acrx20200611_s3.htm S-3 611785
2 EXHIBIT 1.3 ex_190128.htm EX-1.3 28896
3 EXHIBIT 4.4 ex_190035.htm EX-4.4 376437
4 EXHIBIT 4.6 ex_190036.htm EX-4.6 118766
5 EXHIBIT 4.7 ex_190037.htm EX-4.7 119584
6 EXHIBIT 4.8 ex_190038.htm EX-4.8 106685
7 EXHIBIT 5.1 ex_190039.htm EX-5.1 30121
8 EXHIBIT 23.1 ex_190040.htm EX-23.1 3022
9 acrx20200611_s3img001.jpg GRAPHIC 7168
10 acrx20200611_s3img002.jpg GRAPHIC 4843
11 cooleylogo01.jpg GRAPHIC 14596
  Complete submission text file 0001437749-20-013055.txt   1433144
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-239156 | Film No.: 20961068
SIC: 2834 Pharmaceutical Preparations